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Gene expression proﬁling has been widely used to study molecular signatures of many diseases and to develop molecular diagnos-
tics for disease prediction. Gene selection, as an important step for improved diagnostics, screens tens of thousands of genes and
identiﬁes a small subset that discriminates between disease types. A two-step gene selection method is proposed to identify infor-
mative gene subsets for accurate classiﬁcation of multiclass phenotypes. In the ﬁrst step, individually discriminatory genes (IDGs)
are identiﬁed by using one-dimensional weighted Fisher criterion (wFC). In the second step, jointly discriminatory genes (JDGs)
are selected by sequential search methods, based on their joint class separability measured by multidimensional weighted Fisher
criterion (wFC). The performance of the selected gene subsets for multiclass prediction is evaluated by artiﬁcial neural networks
(ANNs) and/or support vector machines (SVMs). By applying the proposed IDG/JDG approach to two microarray studies, that is,
small round blue cell tumors (SRBCTs)and muscular dystrophies (MDs),we successfully identiﬁed a much smaller yet eﬃcient set
of JDGs for diagnosing SRBCTs and MDs with high prediction accuracies (96.9% for SRBCTs and 92.3% for MDs, resp.). These
experimental results demonstrated that the two-step gene selection method is able to identify a subset of highly discriminative
genes for improved multiclass prediction.
Copyright © 2007 Jianhua Xuan et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Molecularanalysisofclinicalheterogeneityincancerdiagno-
sis and treatment has been diﬃcult in part because it has his-
torically relied on speciﬁc biological insights or has focused
on particular genes with known functions, rather than sys-
tematicandunbiasedapproachesforrecognizingtumorsub-
types and associated biomarkers [1–3]. The development of
gene expression microarrays provides an opportunity to take
a genome-wide approach to classify cancer subtypes [2]a n d
to predict therapy outcome [3]. By surveying mRNA expres-
sion levels for thousands of genes in a single experiment, it
is now possible to read the molecular signature of an indi-
vidual patient’s tumor. When the signature is analyzed with
computer algorithms, new classes of cancer that transcend
distinctions based on histological appearance alone emerge,
and new insights into disease mechanisms that move beyond
classiﬁcation or prediction emerge [4].
Although such global views are likely to reveal previously
unrecognized patterns of gene regulation and generate new
hypotheses warranting further study, widespread use of mi-
croarray proﬁling methods is limited by the need for further
technology developments, particularly computational bioin-
formatics tools not previously included by the instruments.
One of the major challenges is the so-called “the curse of di-
mensionality” mainly due to small sample size (10–100 in a
typical microarray study) as compared to large number of
features (often ≥30000 genes). Most commonly used clas-
siﬁers suﬀer from such a “peaking phenomenon,” in that
too many features actually degrade the generalizable perfor-
mance of a classiﬁer [5]. The detrimental impact of small
sample size eﬀect on statistical pattern recognition has led2 EURASIP Journal on Bioinformatics and Systems Biology
to a series of valuable recommendations for classiﬁer designs
[6, 7].
Feature selection has been widely used to alleviate the
curse of dimensionality; the goal being to select a subset of
featuresthatassuresthegeneralizableyetlowestclassiﬁcation
error [5, 8]. Feature selection may be done through an ex-
haustive search in which all possible subsets of ﬁxed size are
examined so that a subset with the smallest classiﬁcation er-
ror is selected [5, 8]. A more elegant yet eﬃcient approach is
based on sequential suboptimal search methods [9, 10]; the
sequential forward ﬂoating selection (SFFS) and sequential
backward ﬂoating selection (SBFS) [10] are among the most
popular methods.
Several studies on gene selection for the molecular classi-
ﬁcation of diseases using gene expression proﬁles have been
reported [2, 11–13]. For example, Golub et al. used signal-
to-noise ratio (SNR) to select informative genes for the two-
classpredictionproblemofdistinguishingacutelymphoblas-
tic leukemia (ALL) from acute myeloid leukemia (AML)
[2]. Khan et al. were the ﬁrst to use an ANN-classiﬁer ap-
proach to select a subset of genes for the multiclass predic-
tion of small round blue cell tumors (SRBCTs) [12]. A sen-
sitivity analysis of ANN’s input-output relations was applied
and identiﬁed a relatively large set of genes (96 genes). Du-
doit et al. extended the two-class SNR method for multi-
ple classes using the ratio of their between-group to within-
group sums of squares, which is essentially a form of one-
dimensional Fisher criterion [11]. Tibshirani et al. proposed
a much simpler method, namely, the “nearest shrunken cen-
troid” method, for SRBCTs classiﬁcation, where a smaller
gene set (43 genes) achieved comparable classiﬁcation per-
formance [14]. The work most closely related to our ap-
proach was reported by Xiong et al. [15]. They argued that
a collection of individually discriminatory genes may not be
the most eﬃcient subset, and considered the joint discrimi-
nant power of genes. Speciﬁcally, they used Fisher criterion
(FC) and sequential search methods to identify the biomark-
ersforthediagnosisandtreatmentofcoloncancerandbreast
cancer [15]. However, it has been shown that when there
are more than two classes, the conventional FC that uses the
squaredMahanalobisdistancebetweentheclassesissubopti-
mal in the dimension-reduced subspace for class prediction.
Speciﬁcally, large between-cluster distances are overempha-
sizedbyFCandtheresultingsubspacepreservesthedistances
of already well-separated classes, causing a large overlap of
neighboring classes [16, 17].
In this paper, we propose to use weighted Fisher crite-
rion (wFC) to select a suboptimal set of genes for multi-
class prediction, since wFC (suboptimally) measures the sep-
arability of clusters and approximates, most closely, the true
mean Bayes prediction error [17]. The weighting function in
wFC criterion is mathematically deduced in such a way that
the contribution of each class pair depends on the Bayes er-
ror rate between the classes. Thus, the wFC criterion deem-
phasizes the contribution from well-separated classes, while
emphasizing the contribution from neighboring classes. A
two-step feature selection is then conducted: (1) individu-
ally discriminatory genes (IDGs) are ﬁrst selected by one-
Two-step gene
selection approach
Individually discriminatory
gene (IDG) selection by
1D-wFC
Jointly discriminatory
gene (JDG) selection by
wFC and SFS
Evaluation by ANN
classiﬁers (MLPs) with
3-fold cross-validation
Figure 1:Blockdiagramofthetwo-stepfeatureselectionapproach.
dimensional wFC; and (2) sequential ﬂoating search meth-
ods are then followed to select jointly discriminatory genes
(JDGs) measured by wFC. The proposed two-step proce-
dure is applied to two data sets—(1) NCI’s SRBCTs and (2)
CNMC’s musculardystrophies—todemonstrateits abilityin
obtaining improved diagnostics for multiclass prediction.
2. METHODS
In an attempt to improve class prediction, we propose a two-
step feature selection approach by combining wFC and the
sequential ﬂoating search (SFS) method. Figure 1 illustrates
the conceptual approach. IDG selection is performed ﬁrst to
identify an initial gene subset of reasonable size (usually 50–
200) under the wFC criterion. An SFS procedure is then con-
ducted to reﬁne the gene subsets of varying size according
to the corresponding joint discriminant power. Finally, two
popular types of classiﬁers, multilayer perceptrons (MLPs)
and support vector machines (SVMs), are constructed to es-
timate the classiﬁcation accuracy when using the selected
gene sets, where the optimal gene subset corresponds to the
smallest classiﬁcation error.
2.1. IDGselectionbywFC
Gene gi (i is an index to a particular gene ID, i = 1,...,N)
will be selected as an individually discriminatory gene (IDG)
ifitsdiscriminantpoweracrossallclusters,measuredbyone-
dimensional wFC (1D wFC),
JIDG

gi

=
K0−1
k=1
K0
l=k+1 pkplω

Δi,kl

μi,k −μi,l
2
K0
k=1 pkσ2
i,k
,( 1 )
isaboveanempiricallydeterminedthreshold,whereK0 isthe
number of clusters, pk is the priori probability of class k,a n d
μi,k is the mean expression level of gene gi in class k,w i t hJianhua Xuan et al. 3
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Figure 2: Weighting function to deemphasize the well-separated
(distant) classes while emphasizing the neighboring (close) classes.
corresponding standard deviations σi,k. The weighting func-
tion, ω(Δi,kl), is designed to give more weight to the proxi-
mate cluster pairs. Figure 2 depicts the ω(Δi,kl) function that
is deﬁned in the following form [17]:
ω

Δi,kl

=
1
2Δ2
i,kl
erf

Δi,kl
2
√
2

,( 2 )
where Δi,kl is gene gi’s Mahanalobis distance between classes
k and l,d e ﬁ n e db y
Δi,kl =
 μi,k −μi,l
 
K0
k=1 pkσ2
i,k
. (3)
Accordingly, we rank genes by JIDG(gi), i = 1,...,N,a n d
select the top M genes as the initial IDGs.
2.2. JDGselectionbywFCandSFS
ClassseparabilitymeasuredbywFC
JDGs refer to the gene subset whose joint discriminatory
power is maximum among all the subsets of the same size
selected from a gene pool (e.g., IDGs). The key is the con-
sideration of the correlation (or dependence) between genes
and their joint discriminatory power. We use multidimen-
sional wFC as the measure of the class separability in JDG
selection. The wFC of JDG can be deﬁned by [17]
J(JDG) =
K0−1 	
k=1
K0 	
l=k+1
pkplω

Δkl

trace

S
−1
w Skl

,( 4 )
where Sw =
K0
k=1 pkSk is the pooled within-cluster scatter
matrix,andSkl = (mk−ml)(mk−ml)T isthebetween-cluster
scattermatrixforclassesk andl;mk andSk arethemeanvec-
torandwithin-classcovariancematrixofclassk,r espectiv ely .
The weighting function, ω(Δkl), is deﬁned as
ω

Δkl

=
1
2Δ2
kl
erf

Δkl
2
√
2

,( 5 )
and Δkl =

(mk −ml)S−1
w (mk −ml) is the Mahalanobis dis-
tance between classes k and l [17]. Note that when the num-
ber of samples is less than the number of genes as in many
gene expression proﬁling studies, the pooled within-cluster
scatter matrix Sw in wFC is likely to be singular, hence result-
ing in a numerical problem in calculating S−1
w .T h e r ea r et w o
possible remedies: the ﬁrst one is to use pseudoinverse in-
stead [18, 19], as originally implemented in [17]; the second
one is to use singular value decomposition (SVD) method.
Practically, we can set those very small singular values (say
<10−5)t oap r e d e ﬁ n e ds m a l lv a l u e( l i k e1 0 −5) for calculating
S−1
w . The second method was used in our implementation of
the algorithm due to its consistent performance as demon-
strated in our experiments.
JDGselectionbySFSmethods
Optimal selection methods such as exhaustive search or the
Branch-and-Bound method [20] are not practical for very
high-dimensional problems such as those that include ex-
pression proﬁling studies. Thus, we will consider alterna-
tive suboptimal methods such as sequential search methods
known as sequential backward selection (SBS) [21] and its
counterpart sequential forward selection [22]. Both suﬀer
from the so-called “nesting eﬀect” that manifests itself ex-
plicitly as follows: (1) in case of SBS the discarded features
cannot be reselected, and (2) in case of sequential forward
selection the features once selected cannot be later discarded.
The plus-l-minus-r method was the ﬁrst method handling
the nesting-eﬀect problem [23]. According to one compara-
tive study [6], the most eﬀectively known suboptimal meth-
ods are the sequential ﬂoating search (SFS) methods [10].
In comparison to the plus-l-minus-r method, the “ﬂoating”
search addresses the “nesting problem” without a need to
specify any parameters such as l or r. The number of forward
(adding)/backward (removing) steps is determined dynami-
cally to maximize the criterion function.
WeuseSFSsearchmethodstoﬁndthesubsetgenes.Asan
example, the SBFS search algorithm is illustrated in Figure 3,
where a ﬂoating search step, called conditionally including
step (CIS), is followed after excluding a feature from the cur-
rent featureset. The CIS is designed tosearchforthe possibly
“best” features from the excluded feature set. In the imple-
mentation, the CIS checks whether the updated feature set
could oﬀer any performance improvement in terms of the
cost function. If improved, CIS will keep searching for the
next “best” feature from the excluded feature set, otherwise
it will return to exclude the next feature. The steps involved
in the SBFS algorithm can be summarized as follows.
Step 1. Exclude the least signiﬁcant feature from the current
subset of size k.L e tk = k −1.4 EURASIP Journal on Bioinformatics and Systems Biology
SBFS
k = 0
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Figure 3: Block diagram of the SBFS search algorithm.
Step 2. Conditionally include the most signiﬁcant feature
from the excluded features.
Step 3. If the current subset is the best subset of size k found
so far, let k = k + 1 and go to Step 2. Else return the
conditionally included feature and go to Step 1.
In the above SBFS algorithm, we say that feature fj from
the set Fk is
(1) the most signiﬁcant (best) feature in the set Fk if
J

Fk − fj

= min
1≤i≤k
J

Fk − fi

;( 6 )
(2) the least signiﬁcant (worst) feature in the set Fk if
J

Fk − fj

= max
1≤i≤k
J

Fk − fi

. (7)
The search algorithm stops when the desired number of fea-
tures is reached. A more detailed description of SBFS and
SFFS algorithms can be found in [10].
2.3. ClassiﬁcationbyMLPsandSVMs
Once selected, the JDGs are fed into neural networks (in
particular, multilayer perceptrons (MLPs)) and/or SVMs for
performance evaluation (see Figure 4). MLPs have been suc-
cessfully applied to solve a variety of nonlinear classiﬁcation
problems [24]. In our experiments, we use three-layer per-
ceptrons where the computation nodes (neurons) in the hid-
den layer enable the network to extract meaningful features
from the input patterns for better nonlinear classiﬁcation.
The connectivity weights are trained in a supervised mannerJianhua Xuan et al. 5
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Figure 4: Evaluation by MLP Classiﬁers with 3-fold cross-validation.
using the error back propagation algorithm [24]. Recently,
SVMs have also been applied to multiclass prediction of tu-
mors using gene expression proﬁles [25, 26]. To overcome
the limitation of SVM being a binary classiﬁer in nature,
Ramaswamy et al. used a one-versus-all (OVA) approach to
achieve multiclass prediction. Each OVA SVM is trained to
maximize the distance between a hyperplane and the clos-
est samples to the hyperplane from the two classes in con-
sideration. Given m classes hence m OVA SVM classiﬁers, a
new sample takes the class of the classiﬁer with the largest
real-valued output, that is, class = argmaxi=1···m fi,w h e r e
fi is the real-valued output of the ith OVA SVM classiﬁer
(one of m OVA SVM classiﬁers). As reported in [25, 26], it
seems that SVMs could provide a better generalizable per-
formance for class prediction in high-dimensional feature
space.
To estimate the accuracy of a predictor for future sam-
ples, the current set of samples was partitioned into a train-
ing set and a separate test set. The test set emulates the
set of future samples for which class labels are to be pre-
dicted. Consequently, the test samples cannot be used in
any way for the development of the prediction model. This
method of estimating the accuracy of future prediction is
the so-called split-sample method. Cross-validation is an
alternative to the split-sample method of estimating pre-
diction accuracy. Several forms of cross-validation exist in-
cluding leave-one-out (LOO) and k-fold cross-validation.
In this paper, we use 3-fold cross-validation (CV) and/or
10-fold CV to estimate the prediction accuracy of the
classiﬁers; if the number of samples is large enough, we
will estimate the prediction accuracy using blind test sam-
ples.6 EURASIP Journal on Bioinformatics and Systems Biology
Table 1: A summary of CNMC’s MD data (CNMC, 2003).
Class Number Type of muscular dystrophy Number of samples
1 BMD—Becker muscular dystrophy (hypomorphic for dystrophin) 5
2 DMD—Duchenne muscular dystrophy 10
3 Dysferlin—Dysferlin deﬁciency; also called Limb-girdle muscular dystrophy 2B (LGMD 2B) 10
4 FSHD—Fascioscapulohumeral dystrophy 14
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Figure 5: IDG selection with 1D wFC: (a) mean and standard deviation of 1D wFC by leave-one-out (LOO) test, and (b) a stability analysis
ofrankingusingbootstrappedsampleswith20,000trials(errorbarindicatesthestandarddeviationoftherankfrombootstrappedsamples).
For3-foldcross-validation,theclassiﬁersaretrainedwith
2/3 of the samples and tested on the remaining 1/3 of the
samples for misclassiﬁcation error calculation (see Figure 4).
The procedures are repeated many shuﬄe times (e.g., 1000
times) of samples to split data set into a training data set and
a testing data set. The overall misclassiﬁcation error rate is
calculated as the mean performance from all the trials.
3. RESULTS
We applied our two-step feature selection approach to two
gene expression proﬁling studies: (1) NCI’s data set of small
r o u n db l u ec e l lt u m o r s( S R B C T s )o fc h i l d h o o d[ 12], and
(2) CNMC’s data set of muscular dystrophies (MDs) [27].
The SRBCT data, consisting of expression measurements on
2,308 genes, were obtained from glass-slide cDNA microar-
rays, prepared according to the standard National Human
Genome Research Institute protocol. The tumors are classi-
ﬁed as one of four subtypes—(1) Burkitt lymphoma (BL),
(2) Ewing sarcoma (EWS), (3) neuroblastoma (NB), and (4)
rhabdomyosarcoma (RMS). A total of 63 training samples
and 25 test samples are provided, although 5 of the latter
are not SRBCTs. The CNMC’s MD data were acquired from
Aﬀymetrix’s GeneChip (U133A) microarrays with a total of
39 sample arrays, consisting of expression measurements on
11,252 genes [28] .T h eg e n ee x p r e s s i o np r o ﬁ l e sw e r eo b -
tained using Aﬀymetrix’s MAS 5.0 probe set interpretation
algorithms [29]. Samples are clinically classiﬁed as either one
of the four types of muscular dystrophy. Table 1 gives a sum-
mary of the four classes in this study and the number of sam-
ples in each class.
3.1. NCI’sSRBCTs
The two-step gene selection procedure was performed on 63
expression proﬁles of NCI’s SRBCTs to identify a subset of
genes. First, IDG gene selection was performed on 63 train-
ing samples to identify the top ranked genes. The individ-
ual discriminant power of each gene was calculated by 1D
wFC. To assess the bias and variance of 1D wFC measure-
ment, we performed leave-one-out trials on the data set. In
Figure 5(a), we show the mean and standard deviation of the
1D wFC measurement. Additional material (Table S1) lists
the top 200 IDGs with gene names and descriptions, which is
available online at our website (http://www.cbil.ece.vt.edu).
In this study, we ranked the IDGs according to the meanJianhua Xuan et al. 7
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Figure 6: JDGs’ prediction performance (NCI’s SRBCTs): Mis-
classiﬁcation error rates calculated by MLPs with 3-fold cross-
validation; error bar indicates the standard deviation.
of the 1D wFC measurement, and obtained 200 top ranked
IDGs to start the second step (i.e., the JDG selection step).
Note that the number 200 was somehow chosen empiri-
cally,however,severalconsiderationswastakenintoaccount.
First, the performance of these 200 IDGs were evaluated
by the classiﬁers to make sure that the MCER was reason-
ably small (indicating the genes’ discriminatory power); sec-
ond, in addition to using leave-one-out test to assess the
bias and variance of 1D wFC measurement, a stability anal-
ysis of ranking using bootstrapped samples was also con-
ducted to support the choice of the IDG number. In this
experiment, 20000 trials of bootstrapping were used to es-
timate the mean and standard deviation of the rank. In
Figure 5(b), we plotted out the rank estimated from leave-
one-out test versus the rank estimated from the bootstrap-
ping trails as well as the standard deviation. Although such
plot could not give us a deﬁnite cut-oﬀ value to determine
the number of IDGs, the standard deviation of the rank es-
timated from bootstrapping trials showed relatively smaller
variations for 100 top ranked IDGs than those for the genes
ranked after 250. It is worth mentioning that the so-called
“neighborhood analysis” described in [2] could also be used
to tackle this problem with the help of a permutation test
method. We have not tried this approach yet due to that
according to our limited knowledge, there exist some dif-
ﬁculties in handing multiple classes and unbalanced sam-
ples.
JDGselectionwasperformedtoselectbestJDGsfromthe
200 IDGs. We used the SBFS method to select the best JDGs
for each given number of features (in this case, the number
of JDGs is from 1 to 199). The prediction performance of
the JDG sets was evaluated by ANN classiﬁers (MLPs) us-
ing misclassiﬁcation error. The MLPs comprised one hid-
den layer with 3 hidden nodes and the misclassiﬁcation er-
rorwascalculatedby3-foldcross-validationwith1,250shuf-
ﬂes. Figure 6 shows the misclassiﬁcation error rate (MCER)
with respect to the selected JDGs, The best prediction per-
formance was obtained when the number of JDGs was 9 in
that MCER = 3.10%. Table 2 shows the image IDs, gene sym-
bols, and gene names of the selected 9 JDGs. Figure 7 shows
the expression pattern of 63 samples in the gene space of the
newly selected 9 JDGs.
As a comparison, we compared the prediction perfor-
mance of our 9 JDGs with that of two other approaches:
(1) 96 genes selected by ANN-classiﬁers [12], and (2) 43
genes selected by a shrunken centroid method [14]. Among
these three sets of genes, we found the following three genes
to be in common: FGFR4 (ImageID:784224), FCGRT (Im-
ageID:770394), and IGF2 (ImageID:207274). The follow-
ing six genes are shared between our 9 JDGs and the 96
genes selected by ANNs: FGFR4 (ImageID:784224), FCGRT
(ImageID:770394), PRKAR2B (ImageID:609663), MAP1B
(ImageID:629896), IGF2 (ImageID:207274), and SELENBP1
(ImageID:80338). The following three genes are shared be-
tween our 9 JDGs with the 43 genes selected by the shrunken
centroid method: FGFR4 (ImageID:784224), FCGRT (Im-
ageID:770394), and IGF2 (ImageID:207274). We used MLPs
(with one hidden layer) to evaluate the prediction perfor-
mance of these three-gene sets; Table 3 shows the compari-
son of these three gene lists in terms of their misclassiﬁcation
error rates. Due to that, two diﬀerent folds were used to es-
timate the prediction performance (3-fold for the 96 genes
selected by ANN-classiﬁers, and 10-fold for the 43 genes se-
lected by a shrunken centroid method), we have conducted
both 3-fold CV and 10-fold CV to estimate the performance
of9JDGs.TheMCERsof9JDGswere3.10%from3-foldCV
and 2.24% from 10-fold CV, respectively. From this equal-
footing comparison, it seemed to suggest that our gene selec-
tion method successfully found a gene list (9 genes, a much
smaller discriminant subset than that selected by either ANN
or the shrunken centroid method) with excellent classiﬁca-
tion performance. It is worthy noting that, although cross-
validation is a proven method for generalizable performance
estimation,diﬀerentfoldsusedinCVmayresultinbiasedes-
timations of the true prediction performance. From our ex-
perience, leave-one-out CV or 10-fold CV tends to oﬀer an
“over promising” performance (i.e., a much lower misclas-
siﬁcation error rate) compared to that of 3-fold CV. If the
number of samples is large enough, we would suggest using
3-fold CV together with a test on an independent data set for
performance estimation.
In addition to the above comparison, we have also com-
pared our method with Dudoit’s method (based on one-
dimensional Fisher criterion) on gene selection for multi-
class prediction [11]. Using SRBCTs data set, we selected
top ranked genes according to Dudoit’s method and used
MLPs to evaluate the prediction performance of the gene
sets with diﬀerent sizes. The estimated MCERs are shown in
Figure 8 for the sets with 3 to 99 genes, where several gene
sets show excellent prediction performance with MCER =
0%. Among those gene sets with MCER = 0%, the small-
est gene set has 22 genes that are available online at our
website (Table S2; http://www.cbil.ece.vt.edu). From this re-
sult, it seemed to suggest that Dudoit’s method oﬀered a8 EURASIP Journal on Bioinformatics and Systems Biology
Table 2: NCI’s SRBCTs: the gene list (with 9 JDGs) identiﬁed by our two-step gene selection method.
I m a g eI D G e n es y m b o l G e n en a m e
784224 FGFR4 ﬁbroblast growth factor receptor 4
195751 AKAP7 A kinase (PRKA) anchor protein 7
81518 OCRL apelin; peptide ligand for APJ receptor
1434905 HOXB7 homeo box B7
770394 FCGRT Fc fragment of IgG, receptor, transporter, alpha
609663 PRKAR2B protein kinase, cAMP-dependent, regulatory, type II, beta
629896 MAP1B microtubule-associated protein 1B
207274 IGF2 Human DNA for insulin-like growth factor II (IGF-2)
80338 SELENBP1 selenium binding protein 1
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Figure 7: Expression pattern of 63 NCI’s SRBCT samples in the gene space of 9 JDGs in Table 2.
slightly better prediction performance for diagnosing SR-
BCTs, although, again, our IDG/JDG method found a much
smaller set of genes with comparable prediction perfor-
mance.
Finally, we tested the classiﬁcation capability of the MLP
classiﬁers using the newly identiﬁed 9 JDGs on a set of 25
blinded test samples. The blinded test samples were 20 SR-
BCTs (6 EWS, 5 RMS, 6 NB, and 3 BL) and 5 non-SRBCTs
for testing the ability of these models to reject a diagnosis.
The non-SRBCTs include 2 normal muscle tissues (Tests 9
and 13), 1 undiﬀerentiated sarcoma (Test 5), 1 osteosarcoma
(Test 3) and 1 prostate carcinoma (Test 11). A sample is clas-
siﬁed to a diagnostic group if it receives the highest vote for
that group among four possible outputs, and all samples will
be classiﬁed to one of the four classes. We then follow the
method described in the supplementary material of [12]—
by calculating the empirical probability distribution of dis-
tance between samples and their ideal output—to set a sta-
tistical cutoﬀ for rejecting a diagnosis that a sample is classi-
ﬁed to a given group. If a sample falls outside the 95th per-
centile of the probability distribution of distance, its diag-
nosis is rejected. As shown in Table 4,w i t ho u r9J D G s ,w e
can successfully classify the 20 SBRCT test samples into their
categories with 100% accuracy. Then we use the 95th per-
centile criterion to conﬁrm and reject the classiﬁcation re-
sults.Forthe5non-SRBCTtestsamples,wecancorrectlyex-
clude them from any of the four diagnostic categories, since
they fall outside the 95th percentiles. For two of the SBRCT
samples (Test 1 and Test 10), however, even though they are
correctly assigned to their categories (NB and RMS, resp.),
their distance from a perfect vote is greater than the expected
95th percentile distance. Therefore, we cannot conﬁdently
diagnose them by the “95th percentile” criterion. The “95th
percentile” criterion also rejected the classiﬁcation result ofJianhua Xuan et al. 9
Table 3: Misclassiﬁcation error rates of MLPs using three diﬀerent gene sets on SRBCTs.
Selection method Number of genes Misclassiﬁcation error rate
ANN (Khan et al. [12]) (3-fold cross-validation) 96 4.08%
IDG/JDG selection by wFC and SFS (3-fold cross-validation) 9 3.10%
Nearest shrunken centroid (Tibshirani et al. [14]) (10-fold cross-validation) 43 3.19%
IDG/JDG selection by wFC and SFS (10-fold cross-validation) 9 2.24%
0
10
20
30
40
50
60
70
80
90
100
M
i
s
c
l
a
s
s
i
ﬁ
c
a
t
i
o
n
e
r
r
o
r
r
a
t
e
(
%
)
10 20 30 40 50 60 70 80 90 100
Number of genes
Figure 8: Prediction performance of the genes selected by Dudoit’s
method (NCI’s SRBCTs): misclassiﬁcation error rates calculated by
MLPs with 3-fold cross-validation; error bar indicates the standard
deviation.
two blind test SBRCT samples (Test 10 and Test 20) with
ANN committee vote using NCI’s 96 genes [12]. Tibshirani
et al. also reported the result on the blind test data set us-
ing their shrunken centroid method. They used the discrim-
inant scores to construct estimates of the class probabilities
in a form of Gaussian linear discriminant analysis [14]. With
the estimated class probabilities, all 20 known SRBCT sam-
ples in the blind test data set were correctly classiﬁed in their
corresponding classes. For the 5 non-SRBCT samples, their
estimated class probabilities were lower than the class prob-
abilities of the 20 SRBCT samples, however, two of them
show a relatively high class probability (> 70%) in RMS cat-
egory, hence, hard to reject their diagnoses as RMS sam-
ples.
3.2. CNMC’sMDs
We applied our two-step gene selection algorithm to
CNMC’s MD data set that consisted of 39 gene expres-
sion proﬁles of 4 types of muscular dystrophies (BDM,
DMD, Dysferlin, and FSHD; see Table 1 for the details).
In the ﬁrst step, the top 100 IDGs were initially selected
by 1D wFC using leave-one-out validation. Additional ma-
terial (Table S3) lists the top 100 IDGs with gene names
and descriptions, which can be found online at our website
(http://www.cbil.ece.vt.edu). Again, the number 100 was
chosen somehow empirically, however, with a preliminary
study of (1) the genes’ discriminatory power in terms of low
MCERs and (2) a stability analysis of ranking using leave-
one-out and bootstrap methods as described in Section 3.1.
In the second step, diﬀerent sets of JDGs were then se-
lected by the SFFS method for the number of genes rang-
ing from 1 to 99. Notice that we used the SFFS method
in this experiment instead of the SBFS as in the SRBCT
study. It has been reported in [6] that the SFFS and SBFS
are of similar performance in ﬁnding suboptimal sets for
class prediction. Our experimental results shown below
supported this conclusion. If the targeted gene sets are
likely small, the SFFS method can oﬀer some computa-
tional advantage over the SBFS approach. The resulting sets
of JDGs were fed into MLPs for performance evaluation.
Figure 9 shows the calculated misclassiﬁcation error rates
(MCERs) achieved by the JDG sets using MLPs with 3-
fold cross-validation. The minimum value of MCER was
14.8% when using 11 JDGs. We also compared the pre-
diction performance of the JDGs with that of the IDGs.
As shown in Figure 10 that the minimum value of MCER
was 15.5% when using 69 IDGs. Therefore, JDGs outper-
formed IDGs not only with a slightly lower MCER, but
also with a much smaller subset of genes. The selected 11
JDGs are listed in Table 5, and the expression pattern of
these 11 JDGs in 39 gene expression proﬁles is shown in
Figure 11.
As a comparison, we also used Dudoit’s method to select
top ranked genes for the MD data set, which can be found
online at our website (Table S4; http://www.cbil.ece.vt.edu).
In this study, we used the OVA SVM approach [26]t oe v a l u -
ate the prediction performance of the genes selected by Du-
doit’s method as well as that of IDGs and JDGs, respectively.
As shown in Figure 12, the MCER of our 11 JDGs is 7.69%
(std = 3.36%), which is much lower than that estimated by
MLPs (i.e., MCER = 14.8%). The minimum MCER of the
genes selected by Dudoit’s method reaches 10.26% (std =
3.55%) using 94 genes, while reaching 5.95% (std = 3.64%)
using 60 IDG genes. Therefore, for this data set, the IDG
selection method (using 1D wFC) outperformed Dudoit’s
method (using 1D FC). The second step in our method, that
is, JDG selection by wFC, can be further used to ﬁnd smaller
gene sets with good prediction performance. In addition to
the 11-JDGs listed before, SVMs also found another set of
JDGs (n = 37; a larger set compared to the 11 JDG set) with
slightly better prediction performance (MCER = 6.51%; std
= 3.51%).10 EURASIP Journal on Bioinformatics and Systems Biology
Table 4: MLP diagnostic predictions using the 9 JDGs in Table 2 on 25 testing SRBCTs.
Sample
lable
MLP committee vote MLP classiﬁcation MLP diagnosis Histological
diagnosis EWS BL NB RMS
Test 1 0.028883 0.17785 0.79642 0.028943 NB ∼ NB-C
Test 2 0.77272 0.21654 0.013751 0.094902 EWS EWS EWS-C
Test 3 0.11429 0.090061 0.32829 0.34814 RMS ∼ Osteosarcoma-C
Test 4 0.000568 0.001845 0.000338 0.99895 RMS RMS ARMS-T
Test 5 0.17165 0.007505 0.55362 0.35478 RMS ∼ Sarcoma-C
Test 6 0.99931 0.000541 0.000381 0.000363 EWS EWS EWS-T
Test 7 0.046811 0.93487 0.005181 0.03 BL BL BL-C
Test 8 0.000629 0.030889 0.94595 0.029323 NB NB NB-C
Test 9 0.44191 0.2341 0.058133 0.15217 EWS ∼ Sk. Muscle
Test 10 0.25353 0.004541 0.085682 0.84684 RMS ∼ ERMS-T
Test 11 0.15522 0.2033 0.30956 0.18985 NB ∼ Prostate Ca.-C
Test 12 0.98211 0.012711 0.005199 0.017581 EWS EWS EWS-T
Test 13 0.11715 0.055632 0.32017 0.41996 RMS ∼ Sk. Muscle
Test 14 0.010447 0.020733 0.97481 0.00498 NB NB NB-T
Test 15 0.007201 0.96229 0.032875 0.001926 BL BL BL-C
Test 16 0.012105 0.069357 0.92035 0.006036 NB NB NB-T
Test 17 0.001885 0.038029 0.030515 0.92519 RMS RMS ARMS-T
Test 18 0.000678 0.96813 0.01893 0.02351 BL BL BL-C
Test 19 0.99899 4.50E-07 0.0009 0.005982 EWS EWS EWS-T
Test 20 0.89893 0.028121 0.006424 0.19883 EWS EWS EWS-T
Test 21 0.94549 0.055391 0.009161 0.037187 EWS EWS EWS-T
Test 22 0.004974 0.000617 0.006337 0.99702 RMS RMS ERMS-T
Test 23 0.032343 0.005809 0.95009 0.027456 NB NB NB-T
Test 24 0.033041 0.005865 0.001679 0.98991 RMS RMS ERMS-T
Test 25 0.039903 0.071522 0.90682 0.007421 NB NB NB-T
Table 5: CNMC’s MDs: the gene list (with 11 JDGs) identiﬁed by our two-step gene selection method. (“+”: up regulated, “−”: down
regulated, and “N”: neither up or down regulated).
Probe set Gene symbol Gene name BMD DMD LDMD2B FSHD Pathophysiology
222280 at — CDNA clone IMAGE:6602785, partial cds + N +++ − Unknown
212488 at COL5A1 collagen, type V, alpha 1 ++ +++ + N Regeneration
200735 x at NACA nascent-polypeptide-associated
complex alpha polypeptide ++ + − Unknown
211734 s at FCER1A Fc fragment of IgE, high aﬃnity I,
receptor for; alpha polypeptide ++ +++ + N Inﬂammation
Degeneration
209156 s at COL6A2 collagen, type VI, alpha 2 ++ +++ + N Fibrosis
208695 s at RPL39 ribosomal protein L39 + + + −− Regeneration
205730 s at ABLIM3 actin binding LIM protein family, member 3 ++ + + −− Regeneration
202966 at CAPN6 Calpain 6 ++ +++ + − Regeneration
205422 s at ITGBL1 integrin, beta-like 1 (with EGF-like repeat domains) + ++ + N Regeneration
202409 at EST (IGF2 3 ) Hypothetical protein oﬀ 3’ UTR of IGF2 ++ +++ ++ N Regeneration
213048 s at I-2PP2A Phosphatase 2A inhibitor I2PP2A +++ + ++ − ProliferationJianhua Xuan et al. 11
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Figure 9: JDGs’ prediction performance (CNMC’s MDs): mis-
classiﬁcation error rates calculated by MLPs with 3-fold cross-
validation; error bar indicates the standard deviation.
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Figure 10: IDGs’ prediction performance (CNMC’s MDs): mis-
classiﬁcation error rates calculated by MLPs with 3-fold cross-
validation; error bar indicates the standard deviation.
A subset of the Fascioscapulohumeral muscular dystro-
phy (FSHD) biopsies has been recently published [32], and
diﬀerentsmallermicroarraysforDuchennemusculardystro-
phy have been published (U95A-E, MuscleChip) [27, 33, 34].
The diﬀerential diagnosis of these four disorders is typically
not diﬃcult. FSHD is an adult disorder showing dominant
inheritance of a subtelomeric deletion of chromosome 4q se-
quence that is detected using DNA tests [32]. This is a repeti-
tive sequence, and it is not clear what the biochemical conse-
quencesofthisdeletionare.Duchennemusculardystrophyis
a childhood disease showing “frame-shift” mutations of the
dystrophin gene, and loss of function of the protein [35, 36].
Becker muscular dystrophy is typically an adult disease, with
“in-frame” deletions of the dystrophin gene leading to pro-
duction of abnormal, yet semifunctional dystrophin protein.
Dystrophin is a component of the plasma membrane cy-
toskeleton in muscle cells (myoﬁbers), where it stabilizes the
membrane. The fourth studied group, dysferlin deﬁciency, is
also called Limb-girdle muscular dystrophy 2B (LGMD 2B).
This isa recessivelyinherited adultdisease thatshows clinical
symptoms very similar to Becker muscular dystrophy, but is
duetolossofatransmembraneprotein,dysferlin,thatseems
involved in vesicle traﬃc. Patients with complete dysferlin-
deﬁciency by immunoblot typically have mutations of the
corresponding gene.
While it is promising to diagnose these four disorders
using molecular signatures, the molecular pathophysiology
downstream of theprimary defectis very poorly understood.
Each of these disorders shows some enigmatic clinical and
histological features, yet these have been diﬃcult to tie to
the primary gene and protein problem. Thus, this data set
and the analysis of this using the two-step IDG/JDG selec-
tion methods described here provide potential new insights
into the molecular pathophysiology of the muscular dystro-
phies. In considering the 11 diagnostic genes, we looked at
what was known about the function of each of these genes,
and then began to build a model for molecular pathophysi-
ology based upon the IDG/JDG analyses.
Eight of the eleven diagnostic genes appear to reﬂect
the degree of severity of the “dystrophic process” in mus-
cle, namely, myoﬁber degeneration, regeneration, and ﬁ-
brosis. For example, Calpain 6 is a calcium sensitive pro-
tease that is known to be involved in fusion of myoblasts
into syncytial myotubes. Consistent with this role, query of
a 27 time point in vivo muscle regeneration series shows
very low expression in normal nonregenerating muscle, but
strong induction of the gene at around day 4 of regener-
ation, at the time point when myoblast fusion takes place
(Figure 13(a))[ 30, 31, 37]. Duchenne muscular dystrophy
is the most clinically and histologically severe of the four
groups studied, and it showed the greatest expression of
Calpain 6, while the other dystrophies showed less expres-
sion likely consistent with the relative amount of regener-
ation in the muscle (Figure 13(b) and Table 5). Seven ad-
ditional probe sets showed similar patterns, including col-
lagen V (ﬁbrosis), FCER1A (mast cells), a ribosomal gene
(L39), an actin binding protein (ABLIM3), an integrin (IT-
GBL1), and a form of IGF2. All show staged induction
during muscle regeneration or ﬁbrosis in other models
[31].
Two probe sets showed unique patterns that likely drove
the performance of the weighted FC in this analysis, but both
are poorly characterized proteins, namely, the Phosphatase
2A inhibitor I2PP2A gene (highly expressed in BMD), and a
cDNAclone(222280 at)thatappearsdiagnosticofLGMD2B
(dysferlin deﬁciency) (Table 5) .T h eI 2 P P 2 Ag e n em a yb ei n -
volved in the more successful regeneration of muscle seen in
many BMD patients compared to the other dystrophies. The12 EURASIP Journal on Bioinformatics and Systems Biology
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Figure 11: Expression pattern of 39 CNMC’s MD samples in the gene space of 11 JDGs in Table 5.
function of the anonymous cDNA clone (222280 at) will be
important to determine, as it may be involved in vesicle fu-
sion functions, as is dysferlin.
4. CONCLUSION
We have applied a gene selection approach to multiclass pre-
diction using gene expression proﬁles. The two-step method
starts with individually discriminatory gene (IDG) selection
using 1D wFC to reduce initially data dimensionality to a
manageablesize.Thejointlydiscriminatorygenes(JDGs)are
then selected by a sequential search method (SFS) to further
reducethedimensionalitytoasmallersize.Theapproachhas
been applied to two microarray studies: (1) small round blue
celltumors(SRBCTs)ofchildhood,and(2)musculardystro-
phies (MDs). The performance of the selected gene lists was
evaluated by ANN classiﬁers (MLPs) and/or SVMs, which
demonstrated that high and generalizable prediction perfor-
mance can be achieved for diagnosing SBCTs and MDs when
gene selection is properly done.
Microarray analysis is a widely used technology for
studying gene expression on a global scale. However, the
technology is presently not used as a routine diagnostic
tool. One diﬃculty in using these high-throughput arrays
for clinical practice would be costly, due to the fact that
synthesizing the necessary polymerase chain reaction (PCR)
primers for such a large number of genes increases produc-
tion costs drastically [38, 39]. As demonstrated in this pa-
per and the others (e.g., [40]), usually the measurements
of a small set of genes are adequate to build a classiﬁer
that distinguishes one disease subtype from another. There-
fore, for diagnosis it is not necessary to screen gene expres-
sion on a whole genome basis, but instead customized mi-
croarrays(i.e.,diagnosticmicroarrays)withconsiderablyless
genes can be used. As an example, researchers have recently
made it possible to convert a breast cancer microarray signa-
ture into a high-throughput diagnostic test [41]. We believe
that our gene selection approach providing a much smaller
set of genes would be an eﬀective tool to help further re-
duce the costs of diagnostic microarrays for clinical appli-
cations.Jianhua Xuan et al. 13
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Figure 12:Predictionperformancecomparison:(1)usingthegenes
selected by Dudoit’s method, (2) using IDGs, and (3) using JDGs
(CNMC’s MDs); misclassiﬁcation error rates calculated by SVMs
with 3-fold cross-validation.
From the experimental results shown in Figures 6 and 8,
we have observed an interesting behavior of MLPs with JDGs
as inputs: with an increase in feature size (i.e., the number of
JDGs),thegeneralizationerrorﬁrstdecreases,thenincreases,
has a maximum at p = N/α (where N is the number of sam-
ples and α is usually found between 2 and 10) and then de-
creases again. This somewhat “strange” behavior was termed
as “peaking phenomenon” [42] or “scissor eﬀect” [43–45].
The behavior was theoretically investigated by Raudys and
Duin and found top be the result of “small size eﬀect” on
theclassiﬁersusingpeudo-Fisherlineardiscriminant(PFLD)
[45]. In [43, 44], it was also shown that under certain condi-
tions, ANNs (in particular, nonlinear single-layer perceptron
(SLP)) can realize the PFLD. We believe that our microar-
ray study results with MLPs provided a strong experimen-
tal support to the theoretical analysis of the “peaking phe-
nomenon.” It is worth noting that some possible approaches
can be utilized to improve the generalization performance
when feature size is much larger than the sample size [42].
One of the approaches is to use support vector machines
(SVMs) that oﬀe ras y s t e m a t i cp r o c e d u r ef o rr e d u c i n gt h e
number of samples in the training set to deﬁne the classiﬁers
[46]. Another possible approach is to use subspace methods
in which each class is approximated by subspace of the fea-
ture space [47]. As pointed out in [42], the subspace meth-
ods can provide us a way to control the complexity of classi-
ﬁers directly, while, in the SVM the number of support vec-
tors, and thereby the classiﬁer complexity, is a result of com-
plexity constraining and cannot be preset in general. In fu-
ture, we will investigate the subspace classiﬁers in conjunc-
tion with a large number of JDGs for improving further the
generalization performance in diagnosing muscular dystro-
phies.
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Figure 13: Diagnostic genes of the muscular dystrophies are often
involved in muscle regeneration. (a) A query of the Calpain 6 diag-
nosticgeneselectedbywFC(seeTable 5)againsta13-groupmuscu-
lar dystrophy data set (see http://pepr.cnmcresearch.org). Calpain 6
is the highest in DMD, as summarized in Table 5.( b )T h eq u e r y
of Calpain 6 in a 27-time point muscle regeneration series in mice
(see http://pepr.cnmcresearch.org; Zhao et al. [30], Zhao and Hoﬀ-
man [31]). Calpain 6 shows very low expression at time 0 (normal
muscle) with strong induction at time points at days 4–8, consistent
with its role in myoblast fusion to myotubes (regeneration).
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